851046-49-6

Basic information

• Product Name: 3-({2,2-dimethyl-6-[6-(3-phenyl-ureido)-purin-9-yl]-tetrahydro-furo[3,4-d][1,3]dioxole-4-carbonyl}-amino)-benzoic acid methyl ester
• CAS NO: 851046-49-6
• Molecular Weight: 573.565
• Mol File: 851046-49-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-({2,2-dimethyl-6-[6-(3-phenyl-ureido)-purin-9-yl]-tetrahydro-furo[3,4-d][1,3]dioxole-4-carbonyl}-amino)-benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-({2,2-dimethyl-6-[6-(3-phenyl-ureido)-purin-9-yl]-tetrahydro-furo[3,4-d][1,3]dioxole-4-carbonyl}-amino)-benzoic acid methyl ester(851046-49-6)
• EPA Substance Registry System: 3-({2,2-dimethyl-6-[6-(3-phenyl-ureido)-purin-9-yl]-tetrahydro-furo[3,4-d][1,3]dioxole-4-carbonyl}-amino)-benzoic acid methyl ester(851046-49-6)

Safety Data

• Hazardous Substances Data: 851046-49-6(Hazardous Substances Data)

Upstream product

• 58-61-7 adenosine 
• 19234-66-3 2',3'-isopropylideneadenosine-5'-carboxylic acid 

Relevant articles and documents

NON-NUCLEOTIDE COMPOSITIONS AND METHOD FOR TREATING PAIN

The present invention is directed to a method of treating pain. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a P2X receptor antagonist. The methods of the present invention are useful in reducing pain, such as traumatic pain, neuropathic pain, organ pain and/or pain associated with diseases. The P2X receptor antagonists useful for this invention are non-nucleotide compounds of general Formula I. Compounds of Formula I can be used alone to treat pain. Compounds of Formula I can also be used in conjunction with other therapeutic agents or adjunctive therapies commonly used to treat pain, thus enhancing the therapeutic effect of pain reduction.